American International Group, Inc. Seelos Therapeutics, Inc. Transaction History

American International Group, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$0.51 - $0.93 $24,873 - $45,357	-48,772 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$0.84 - $1.71 $2,884 - $5,872	-3,434 Reduced 6.58%	48,772 $41,000
Q4 2021 Feb 11, 2022	SELL	$1.59 - $2.38 $2,483 - $3,717	-1,562 Reduced 2.91%	52,206 $85,000
Q3 2021 Nov 12, 2021	BUY	$1.69 - $2.89 $19,076 - $32,622	11,288 Added 26.57%	53,768 $130,000
Q2 2021 Aug 13, 2021	BUY	$2.64 - $6.32 $112,147 - $268,473	42,480 New	42,480 $112,000

40.5K

Ticker SEEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 106,691,000
Market Cap $400M
Description
Seelos Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of central nervous system, respiratory, and other disorders. The company's lead programs are SLS-002, an intranasal racemic ketamine for the treatment of acute suicidal ideation and behavior in...

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

Stay updated on American International Group, Inc. with notifications on news.